Background Previous cost analyses of laparoscopic resection for colorectal cancer (CRC) reported slightly higher or similar costs to those of open resection. These analyses were based on randomised controlled trials when the laparoscopic approach was newly adopted. This study compared costs for laparoscopic versus open resection in a region of high uptake where adoption is mature. Methods Hospital cost data were obtained for elective resections for CRC that occurred between June 2009 and June 2011 in public hospitals in Queensland, Australia. The primary outcome was total cost and secondary outcomes were length-of-stay, operating time, and ICU admission. Multivariate least-squares regression was used to adjust for potential confounders: age, sex, comorbidities, procedure, and hospital volume. Results The crude mean cost for laparoscopic resection was €20,036 compared with that for open resection of €22,780 (difference = €2,744). Patients who underwent laparoscopic resection (744/1,397; 53 %) were slightly younger and had fewer comorbidities (decreasing costs) but more had rectal surgery (increasing costs). The adjusted mean cost for laparoscopic resection was €20,396 compared with €22,442 for open resection (difference = €2,054). Compared with open resection, when adjusted for potential confounders, laparoscopic resection resulted in similar operating time (216 vs. 214 min), shorter length-of-stay (difference = -1.1 days, 95 % CI -1.9, -0.3), and shorter admission to ICU (difference = -7.3 h, 95 % CI -11.9, -2.7). Conclusions This non-randomised study in a region of high uptake found a similar operating time and lower cost for laparoscopic resection for CRC compared with those of open resection due to a shorter length-of-stay and shorter time in ICU. Laparoscopic resection for CRC saves money when the procedure is widely adopted and surgeons are experienced in the technique.
High-quality evidence from randomised controlled trials (RCTs) shows that when compared with open resection, laparoscopic resection for colorectal cancer (CRC) results in less intraoperative blood loss, less postoperative pain, faster return of bowel function, shorter length-of-stay [1, 2] , and lower risk of thromboembolism [2] . Clinical effectiveness is essential for the adoption of new technology in healthcare; however, healthcare administrators must consider the economic value of new technologies. Published analyses have reported that the cost of laparoscopic resection for CRC is similar or slightly greater than the costs for open resection [3] [4] [5] [6] [7] . While fewer complications and shorter length of hospital stay result in reduced costs, previous studies have reported increased costs associated with the specialised equipment required for laparoscopic resection and increased costs associated with longer operating times [8] . For example, the Australasian Laparoscopic Colon Cancer Study (ALCCaS) reported an increased cost of disposable equipment in the operating theatre of $AUD274 [7] . Similar additional costs have been reported in the US [9] and UK [4] . Franks et al. [4] reported longer operating times for laparoscopic resections of CRC leading to increased costs for theatre staff of £114 per operation in the UK.
Cost analyses of laparoscopic resection for CRC, to date, were based predominantly on RCTs performed when the procedures were in the early stage of adoption of laparoscopic resection for CRC. As the level of experience, patient selection, techniques, and equipment for surgical procedures change over time, so too do the associated costs. For example, patients excluded from the RCTs in the early 1990s are now routinely considered for laparoscopic resection, specifically for resection of rectal cancer which is known to be more expensive than that for colon cancer [10] . Also, with experience, the operating time for laparoscopic resection can be similar to that for open resection [11] . It is therefore possible that as uptake of laparoscopic resection moves from the innovators to the early adopters and on to an early/late majority [12] , the increased cost associated with the longer operating time for laparoscopic resection of CRC will decrease and may even result in cost savings compared with open resection.
Queensland is the third largest state of Australia with a population of 4.6 million. Surgeons in Queensland adopted laparoscopic resection for CRC early [13] , and adoption has been faster than in any other state in Australia [14] and faster than in most other places around the world [15] [16] [17] . Training courses in laparoscopic resection of the colon and rectum were conducted by a group of colorectal surgeons in Queensland during the early 2000s, providing experience in this technique to surgeons in the early period of adoption. Currently, more than 50 % of resections for CRC in public hospitals in Queensland are laparoscopic. This study includes all CRC patients admitted to public hospitals for an elective resection of the colon or rectum and provides a ''real world'' cost assessment done on unselected patients. The specific research question is: What are the differences in total and component (e.g., theatre, ICU) costs for laparoscopic versus open resection for CRC in a region with high uptake?
Methods

Data
This study was based on data drawn from the statewide Transition II Clinical Costing database with standardised feeder systems and processing. The database's main role is to support activity-based funding and it is also regularly used by researchers to undertake cost studies [18] . It is a comprehensive collation of cost information associated with the provision of services to individual patients treated in public hospitals, including resource utilisation in the operating theatre such as anaesthetics, pharmacy, pathology, clinical imaging, and other allied health resources, as well as general resources associated with hospital admission and stay on the hospital ward and associated with hospital administration. It does not include costs associated with surgical training outside of the operating theatre.
Transition II collects information for public hospitals, where patients receive treatment without any out-of-pocket costs. Resections performed in private hospitals, where the cost of treatment is covered by a combination of government subsidy, private health insurance, and patient payments, were excluded. About 60 % of CRC patients in Queensland are treated in private hospitals; this paper focuses on the 40 % treated in public hospitals.
Total cost of the index admission for resection was obtained from Transition II for 1,273 of the 1,391 patients treated for CRC in public hospitals (92 %). Component costs of interest included theatre, anaesthetics, pharmacy, clinical imaging, and pathology; these costs were obtained for 1,315 of the 1,391 patients (95 %).
Patient level cost data in Transition II is a collation of costs specific to the care of an individual patient, average cost of resources associated with admission, and standard daily costs. For instance, the cost of the staff in the operating theatre for an individual patient is calculated as [cost allocated for each clinician (surgeons and nurses) multiplied by the number of minutes spent in the operating theatre]. The costs specific to the care of a patient also includes the costs associated with anaesthesia and disposable surgical equipment (single use such as the harmonic scalpel). The cost of clinical consumables is based on the average cost specific to the surgical procedure. Costs associated with stays in the hospital ward are set at a per diem or per shift rate and include the cost for items such as laundry and meals. Admissions to the ICU are allocated at a standard cost per minute per patient.
The de-identified, unit-record data from Transition II was for the period from June 2009 to June 2011. Data extraction was limited to patients with CRC who had an elective surgical resection. Patients who had undergone an emergency resection (e.g., for bowel obstruction, bleeding, or perforation secondary to CRC) or a Hartmann procedure were excluded because these are not routinely considered for the laparoscopic approach.
Statistical analysis
Costs are presented in €2012 after inflating Australian dollars to 2012 using the Australian consumer price index [19] and converting to euros [20] (AUD1 = €0.81354).
Hospitals were categorised as high volume if they performed at least 80 resections for CRC over the 2-year study period. Procedures were grouped according to their relative technical difficulty (see Tables 1 and 2 ). The intention-totreat principle was applied throughout the analyses.
The t test was used to compare the unadjusted mean cost of laparoscopic resection with that of open resection, and multivariate, ordinary-least-squares regression analysis was used to compare the adjusted mean cost after accounting for differences in age, sex, Dukes stage, Charlson comorbidity index (excluding diagnosis codes for CRC and metastatic cancer), hospital volume (high/low), and type of procedure (e.g., right hemicolectomy, anterior resection). The robust variance method of Huber and White was used to account for any heteroscedasticity [21] .
Cost data are known to be right-skewed (i.e., a few patients have very high costs) [22] . For a small sample size, right-skewed data can invalidate statistical inferences based on multivariate, ordinary-least-squares regression. However, for the large sample available for this study, simulation studies have shown that statistical inferences based on multivariate ordinary-least-squares regression are valid [22] . Also, mean costs are preferred by service planners and budget holders [22] . Nevertheless, to confirm the robustness of our conclusions, we also provide adjusted median costs using absolute residuals regression [23] . Marginal analysis was used to determine the adjusted means from the ordinary-least-squares regression model. All analyses were performed using STATA ver. 11 (StataCorp, College Station, TX, USA).
Ethical approval for this study was granted by the Queensland Health Human Research Ethics Committee and the University of Queensland School of Population Health Human Research Ethics Committee.
Results
Over the 2 years of the study, 1,391 patients had elective resection for CRC in 18 public hospitals. Eight hospitals were high volume ([80 major resections during the 2 years) and accounted for 1,031 (74 %) of the resections. The mean age of the patients was 67 years, 800/1,397 (57 %) were men, and 670/1,391 (48 %) had rectal surgery.
Slightly more than half of the patients (744/1,391; 53 %) had a laparoscopic resection, which was more common in younger patients with no comorbidities and those who were treated in high-volume hospitals (Table 1) . Laparoscopic resection was performed more often for anterior (and high anterior) resections of the rectum (Table 1) , reflecting the centralisation of rectal surgery to high-volume hospitals. Open surgery was more common for resections of the sigmoid, transverse, and right colon (Table 1) .
Of the 1,391 patients, 17 (1.2 %) died while in hospital for resection (open: 13 deaths; laparoscopic: 4 deaths). Exclusion of the deaths did not affect the cost results; all cost analyses include the costs for those who died.
The unadjusted mean cost was €20,036 for laparoscopic resection and €22,780 for open resection (difference = €2,744). The unadjusted median cost was €17,008 for laparoscopic resection and €18,094 for open resection (difference = €1,086). 
Factors influencing total cost, length of hospital stay, surgery duration, and time spent in the ICU are listed in Table 2 . Older patients, those with comorbidities, those with metastases, and those who had rectal surgery incurred greater costs. Patients treated in high-volume hospitals incurred lower costs. Increased costs for the rectal procedures (abdominoperineal resection, anterior resection, and ultralow anterior resection) coincide with increased lengthof-stay and operating time ( Table 2) .
After accounting for any differences in age, sex, comorbidities, stage, type of procedure, and hospital volume, the adjusted mean cost for laparoscopic resection was €20,369 compared with €22,442 for open resection (difference = €2,053) ( Table 3 ). The adjusted median cost was €808 (95 % CI €33, €1,584) less for laparoscopic resection.
Most of the difference in cost (mean or median) was accounted for by a shorter length-of-stay and fewer and shorter ICU admissions. Including length-of-stay in the adjusted model decreased the mean difference in cost to €314 (95 % CI -€1,215, €587), while including admission to ICU reduced the mean difference in cost to €841 (95 % CI -€2,290, €608).
To further check the robustness of the finding that laparoscopic surgery is associated with substantially lower costs than open surgery, we conducted an analysis on a homogeneous subgroup, similar to patients recruited to RCTs for laparoscopic surgery (\80 years of age, no metastasis, no preplanned ICU admission, no chronic pulmonary disease, and no pre-existing heart failure). After adjusting for age, sex, stage, comorbidities, type of surgery, and hospital volume within this subgroup, the results were similar to those for the entire study population. Specifically, the adjusted mean cost was €18,917 for laparoscopic resection and €20,986 for open resection (difference = €2 068; 95 % CI €379, €3,758). Similarly, a separate analysis restricted to highvolume hospitals found that the difference in adjusted mean cost was €2,107 (95 % CI €458, €3,756). ICU admission (224 patients) was more frequent for open versus laparoscopic resection patients (22.6 % vs. 10.5 %, P \ 0.001). Preplanned ICU admissions were more common among patients who had open resection (70/647; 10.8 %) than those who had laparoscopic resection (43/744; 5.8 %). Patients who had a prebooked ICU admission were older and more likely to have had comorbidities; these factors, along with procedure type and hospital volume, were included in the multivariate analysis, i.e., the analysis adjusted for these differences. To further assess the possible effect of prebooked ICU admissions, we conducted analyses excluding these patients. The adjusted mean costs decreased to €19,754 for laparoscopic resection and €21,350 for open resection (difference = €1,595; 95 % CI €18, €3,173), and the difference in time in ICU decreased to -5.4 h (from -7.3 h; Table 2 ). In short, the results were robust to the effect of preplanned ICU admissions.
Discussion
This study of a region where uptake of laparoscopic resection for CRC is mature found that it is significantly less expensive than open resection for CRC. This coincides with laparoscopic patients having a shorter length of hospital stay, fewer and shorter admissions to the ICU, and equivalent operating time compared with open resection patients.
In 2006, the National Institute of Health and Clinical Excellence (NICE) in the UK found that laparoscopic surgery for CRC was slightly more expensive (£265) compared with open resection [24] . Franks et al. [4] reported similar results based on patients recruited into the MRC CLASICC trial (UK) between 1996 and 2002. However, the mean cost (inflated to 2013 from 1999) [25] reported by NICE was about half that found in our study; €10,833 (£9,186) for the laparoscopic group compared with €10,415 (£8,829) for the open group [24] . Similarly, Norwood et al. [7] , who compared costs using a cohort from the ALCCaS RCT, reported total costs of admission that were less than half that found in this study [7] . As their results were based on patients recruited into RCTs, the cost comparisons by NICE and Norwood et al. [7] exclude patients who needed more complex care and thus have the associated higher costs.
The ALCCaS RCT reports an operating time for laparoscopic resection 60 min longer than that for open resection, resulting in statistically significant increased costs for the operating surgeon, anaesthetist, and operating room staff [7] . In our study, there was no difference in the operating times of the two approaches, indicating that the difference in theatre costs was due to equipment use rather than time-dependent resources such as staffing. The ALCCaS RCT reported an increased cost in disposable surgical equipment used in the operating theatre of €215 ($AUD274) for the laparoscopic group [7] , which is slightly more than the unadjusted mean increase in theatre cost of €120 found in the current study. This slightly lower cost associated with disposable surgical equipment is due probably in part to the more experienced surgeons who have developed efficient techniques including a reduction in the use of staples. Like all observational (nonrandomised) studies, the present study could be subject to confounding, i.e., the lower cost for laparoscopic versus open surgery could be due to differences in the types of patients rather than the laparoscopic approach, per se. Laparoscopic patients were slightly less likely to have some characteristics that tend to increase costs, e.g., age [ 75 years, metastases, comorbidities, and treatment in a low-volume hospital. On the other hand, they were more likely to have a rectal procedure, which tends to increase cost. The results of our study were adjusted for these potential confounders. This is also the case for factors that may have contributed to preplanned admission to ICU (i.e., age and comorbidities). In addition, we defined a more homogeneous subgroup (\80 years of age, no metastasis, no preplanned ICU admission, no chronic pulmonary disease, no pre-existing heart failure) and still found a difference in cost of about €2,000. Also, a separate analysis of just high-volume hospitals similarly found that the adjusted mean total cost was about €2,100 lower for laparoscopic resection than for open resection.
In conclusion, the results of this study are different from those of earlier studies, which have reported similar or slightly higher costs for laparoscopic versus open resection for CRC. Laparoscopic resection has a lower cost than open resection probably because Queensland is further along the adoption curve of laparoscopic resection and the majority of surgeons are very experienced with the procedure. For instance, previous studies have reported longer operating times for laparoscopic resection [8] , while this study found no difference in operating time, even after adjusting for potential confounders such as procedure type and comorbidities.
The findings of this study indicate that in regions where the procedure is widely adopted and surgical teams are experienced in the technique, there will be cost savings associated with laparoscopic resection for colorectal cancer because of fewer admissions to ICU and decreases in operating time and length-of-stay. Specific inferences regarding the degree of cost benefit in other settings will depend on the relative cost of these determinants. For instance, it may be inferred that healthcare systems where hospital bed days are more expensive than in this study will see a greater cost benefit.
